Featured
Kohler Wisconsin Redefines Wellness Retreats with Integrated Design
Clinic Moves Sep 26, 2026
Trial Briefs Sep 25, 2026
Vaccine News Sep 24, 2026
Kohler Wisconsin redefines wellness retreats with integrated design, blending movement, recovery, and architecture into a...
FDA reviews two novel ADHD drug candidates in late-stage development, offering new approaches to treatment.
Zorevunersen dravet patients showed adaptive gains over two years, surpassing standard antiseizure therapy in a...
Read our latest Drug Approvals articles.
Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and...
Vonoprazan significantly reduces nighttime reflux symptoms in patients with NERD, offering a promising new treatment...
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial...
Noninvasive tests now replace risky liver biopsies for diagnosing metabolic dysfunction-associated steatohepatitis (MASH) and MASLD, offering safer, cost-effect
Noninvasive tests now replace risky liver biopsies for diagnosing metabolic dysfunction-associated steatohepatitis (MASH) and MASLD, offering safer, cost-effect
Stubborn eczema may signal hidden conditions, so the American Academy of Dermatology now urges doctors to run new tests before...
The new American Association of Neurology and American Headache Society guideline outlines migraine preventive pharmacologic treatment for adults,.
Early kidney disease diagnosis rates remain stagnant despite increased screening, highlighting challenges in healthcare detection.
Vonoprazan significantly reduces nighttime reflux symptoms in patients with NERD, offering a promising new treatment option for better sleep.
New diagnostic guidelines for suspected epilepsy focus on ruling out seizures and classifying focal or generalized types—experts emphasize patient history...
Zorevunersen dravet patients showed adaptive gains over two years, surpassing standard antiseizure therapy in a study at the Epilepsy Congress.
New study finds valbenazine significantly improves quality of life for adults with tardive dyskinesia.
Discover how dual therapy is reshaping spinal muscular atrophy treatment as experts debate combining treatments to improve SMA patient outcomes.
The American Academy of Neurology and American Headache Society released an updated migraine prevention guideline for adults, replacing the 2012.